These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1999849)

  • 1. Cancer registry problems in classifying invasive bladder cancer.
    Lynch CF; Platz CE; Jones MP; Gazzaniga JM
    J Natl Cancer Inst; 1991 Mar; 83(6):429-33. PubMed ID: 1999849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problems in cancer surveillance: delineating in situ and invasive bladder cancer.
    Hankey BF; Edwards BK; Ries LA; Percy CL; Shambaugh E
    J Natl Cancer Inst; 1991 Mar; 83(6):384-5. PubMed ID: 1999842
    [No Abstract]   [Full Text] [Related]  

  • 3. Bladder Cancer Stage Development, 2004-2014 in Europe Compared With the United States: Analysis of European Population-based Cancer Registries, the United States SEER Database, and a Large Tertiary Institutional Cohort.
    Schulz GB; Grimm T; Buchner A; Jokisch F; Kretschmer A; Stief CG; Knüchel R; Kraywinkel K; Karl A
    Clin Genitourin Cancer; 2020 Jun; 18(3):162-170.e4. PubMed ID: 31956010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demographic and Survivorship Disparities in Non-muscle-invasive Bladder Cancer in the United States.
    Seo M; Langabeer Ii JR
    J Prev Med Public Health; 2018 Sep; 51(5):242-247. PubMed ID: 30286596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006.
    Nielsen ME; Smith AB; Meyer AM; Kuo TM; Tyree S; Kim WY; Milowsky MI; Pruthi RS; Millikan RC
    Cancer; 2014 Jan; 120(1):86-95. PubMed ID: 24122346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of bladder cancer in patients diagnosed with other primary neoplasms: analysis of the SEER database.
    Anderson JK; Alanee S; Lindgren B; Slaton J
    Urol Oncol; 2013 Aug; 31(6):862-5. PubMed ID: 21784673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The National Cancer Institute's SEER registry and primary malignant osseous spine tumors.
    Nathoo N; Mendel E
    World Neurosurg; 2011 Dec; 76(6):531-2. PubMed ID: 22251499
    [No Abstract]   [Full Text] [Related]  

  • 8. Surveillance for cancers associated with tobacco use--United States, 1999-2004.
    Stewart SL; Cardinez CJ; Richardson LC; Norman L; Kaufmann R; Pechacek TF; Thompson TD; Weir HK; Sabatino SA;
    MMWR Surveill Summ; 2008 Sep; 57(8):1-33. PubMed ID: 18772853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coding criteria of bladder cancer: effects on estimating survival.
    Patriarca S; Gafà L; Ferretti S; Vitarelli S; Cesaraccio R; Crocetti E; Ferrante MC; Rollo P; Tagliabue G
    Epidemiol Prev; 2001; 25(3 Suppl):42-7. PubMed ID: 11695203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival following the diagnosis of noninvasive bladder cancer: WHO/International Society of Urological Pathology versus WHO classification systems.
    Schned AR; Andrew AS; Marsit CJ; Zens MS; Kelsey KT; Karagas MR
    J Urol; 2007 Oct; 178(4 Pt 1):1196-200; discussion 1200. PubMed ID: 17698105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine Learning Methods to Identify Missed Cases of Bladder Cancer in Population-Based Registries.
    Noone AM; Lam CJK; Smith AB; Nielsen ME; Boyd E; Mariotto AB; Banerjee M
    JCO Clin Cancer Inform; 2021 Jun; 5():641-653. PubMed ID: 34097440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
    Milano AF
    J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding bladder cancer death: tumor biology versus physician practice.
    Morris DS; Weizer AZ; Ye Z; Dunn RL; Montie JE; Hollenbeck BK
    Cancer; 2009 Mar; 115(5):1011-20. PubMed ID: 19152434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is microstaging of early invasive cancer of the urinary bladder possible or useful?
    Platz CE; Cohen MB; Jones MP; Olson DB; Lynch CF
    Mod Pathol; 1996 Nov; 9(11):1035-9. PubMed ID: 8933512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive Cancer Incidence and Survival--United States, 2012.
    Henley SJ; Singh SD; King J; Wilson RJ; O'Neil ME; Ryerson AB
    MMWR Morb Mortal Wkly Rep; 2015 Dec; 64(49):1353-8. PubMed ID: 26678069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A plea for better coding rules for bladder cancer.
    Schouten LJ; Kiemeney LA
    Br J Cancer; 1993 Dec; 68(6):1254-5. PubMed ID: 8260382
    [No Abstract]   [Full Text] [Related]  

  • 17. Invasive cancer incidence and survival--United States, 2011.
    Henley SJ; Singh SD; King J; Wilson R; O'Neil ME; Ryerson AB;
    MMWR Morb Mortal Wkly Rep; 2015 Mar; 64(9):237-42. PubMed ID: 25763875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing Cancer Registry Abstracted and Self-Reported Data on Race and Ethnicity.
    Atekruse SF; Cosgrove C; Cronin K; Yu M
    J Registry Manag; 2017; 44(1):30-3. PubMed ID: 29595942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review of population-based bladder cancer registries: How criteria heterogeneity affects the comparison of incidences.
    Caballero JM; Gili JM; Pereira JC; Gomáriz A; Castillo C; Martín-Baranera M
    Cancer Med; 2023 Mar; 12(6):7540-7551. PubMed ID: 36530046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive Cancer Incidence, 2004-2013, and Deaths, 2006-2015, in Nonmetropolitan and Metropolitan Counties - United States.
    Henley SJ; Anderson RN; Thomas CC; Massetti GM; Peaker B; Richardson LC
    MMWR Surveill Summ; 2017 Jul; 66(14):1-13. PubMed ID: 28683054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.